Gut Microbiota Alterations Associated with Viral Activity in Chronic Hepatitis B
Archives of Case Reports · 24.03.2026 · 021-029
DOI: 10.29328/journal.acr.1001185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Case Reports, online erschienen am 24.03.2026. Verfasst von Paola Nasta und 3 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The gut–liver axis plays a pivotal role in chronic liver diseases, and increasing evidence links gut microbiota dysbiosis to disease progression in chronic hepatitis B (CHB). However, data comparing microbiota features between patients with active and inactive HBV infection remain limited.
Methods
We performed a retrospective analysis of gut microbiota composition and functional potential in patients with chronic HBV infection, stratified according to viral activity as defined by current EASL guidelines. Microbial diversity, taxonomic composition, enterotypes, pathobiont prevalence, and predicted metabolic pathways were compared between active and inactive HBV infection.
Results
Patients with active HBV infection exhibited significantly reduced microbial α-diversity, lower phylogenetic diversity, and decreased evenness compared with inactive carriers, despite virological suppression under antiviral therapy. Active HBV was associated with Prevotella-dominated enterotypes, expansion of pathobionts (Escherichia coli, Klebsiella pneumoniae, Bacteroides fragilis), and depletion of beneficial symbionts, particularly short-chain fatty acid– and indole-producing taxa, including Faecalibacterium prausnitzii, Roseburia intestinalis, Blautia wexlerae, and Alistipes spp. Functional profiling revealed reduced production of butyrate, propionate, acetate, and indole derivatives, alongside increased synthesis of ethanol, secondary bile acids, and lipopolysaccharides.
Conclusion
Active CHB is characterized by a distinct dysbiotic and pro-inflammatory gut microbiota profile that persists despite effective antiviral therapy. These findings support a contributory role of gut microbiota in immune dysregulation and disease activity in CHB and provide a rationale for microbiota-targeted interventions as complementary therapeutic strategies.
Zitieren
APA
Nasta, P., Gregorio, M. D., Zaia, M., & Carosi, G. (2026). Gut Microbiota Alterations Associated with Viral Activity in Chronic Hepatitis B. Archives of Case Reports, 021-029. https://doi.org/10.29328/journal.acr.1001185
Vancouver
Nasta P, Gregorio MD, Zaia M, Carosi G. Gut Microbiota Alterations Associated with Viral Activity in Chronic Hepatitis B. Archives of Case Reports. 2026:021-029. doi:10.29328/journal.acr.1001185
BibTeX
@article{Nasta2026,
author = {Nasta, Paola and Gregorio, Marco Di and Zaia, Monica and Carosi, Giampiero},
title = {Gut Microbiota Alterations Associated with Viral Activity in Chronic Hepatitis B},
journal = {Archives of Case Reports},
year = {2026},
pages = {021--029},
doi = {10.29328/journal.acr.1001185}
}
EUVIMED